Cargando…

The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review

Over the last 40 years osteosarcoma (OS) survival has stagnated with patients commonly resistant to neoadjuvant MAP chemotherapy involving high dose methotrexate, adriamycin (doxorubicin) and platinum (cisplatin). Due to the rarity of OS, the generation of relevant cell models as tools for drug disc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tippett, Victoria L., Tattersall, Luke, Ab Latif, Norain B., Shah, Karan M., Lawson, Michelle A., Gartland, Alison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859755/ https://www.ncbi.nlm.nih.gov/pubmed/36434179 http://dx.doi.org/10.1038/s41388-022-02529-x

Ejemplares similares

The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties
por: Tattersall, Luke, et al.
Publicado: (2021)

YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD522
por: Green, Darrell, et al.
Publicado: (2023)

Distinct Concentration-Dependent Molecular Pathways Regulate Bone Cell Responses to Cobalt and Chromium Exposure from Joint Replacement Prostheses
por: Shah, Karan M., et al.
Publicado: (2021)

Effects of chronic cobalt and chromium exposure after metal‐on‐metal hip resurfacing: An epigenome‐wide association pilot study
por: Steinberg, Julia, et al.
Publicado: (2017)

Osteocyte physiology and response to fluid shear stress are impaired following exposure to cobalt and chromium: Implications for bone health following joint replacement
por: Shah, Karan M., et al.
Publicado: (2016)

Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma
por: Hattinger, Claudia Maria, et al.
Publicado: (2023)

Mechanisms of methotrexate resistance in osteosarcoma cell lines and strategies for overcoming this resistance
por: WANG, JIANJUN, et al.
Publicado: (2015)

Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
por: Hattinger, Claudia Maria, et al.
Publicado: (2021)

Immunotherapeutic Strategies in the Management of Osteosarcoma
por: Supra, Rajiv, et al.
Publicado: (2023)

Relevance of 3d culture systems to study osteosarcoma environment
por: De Luca, Angela, et al.
Publicado: (2018)

In Vitro Strategies to Vascularize 3D Physiologically Relevant Models
por: Dellaquila, Alessandra, et al.
Publicado: (2021)

Using the ADDIE Model to Develop a Rusnani Concept Mapping Guideline for Nursing Students
por: Ab Latif, Rusnani, et al.
Publicado: (2020)

Mapping the Single-cell Differentiation Landscape of Osteosarcoma
por: Truong, Danh D., et al.
Publicado: (2023)

Special Issue “Osteosarcomas: Treatment Strategies”
por: Park, See-Hyoung
Publicado: (2023)

Stressors and Coping Strategies during Clinical Practice among Diploma Nursing Students
por: Ab Latif, Rusnani, et al.
Publicado: (2019)

Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies
por: Chen, Ruiling, et al.
Publicado: (2019)

miR‐15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo
por: Duan, Zhenfeng, et al.
Publicado: (2016)

Exosomes and osteosarcoma drug resistance
por: Fu, Huichao, et al.
Publicado: (2023)

Combination Therapy with Disulfiram, Copper, and Doxorubicin for Osteosarcoma: In Vitro Support for a Novel Drug Repurposing Strategy
por: Mandell, Jonathan B., et al.
Publicado: (2019)

Natural Killer and T Cell Infiltration in Canine Osteosarcoma: Clinical Implications and Translational Relevance
por: Razmara, Aryana M., et al.
Publicado: (2021)

Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures
por: Tan, Jianye, et al.
Publicado: (2022)

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
por: Ando, Kosei, et al.
Publicado: (2013)

Molecular pathogenesis and therapeutic strategies of human osteosarcoma
por: Denduluri, Sahitya K, et al.
Publicado: (2016)

PDGF/PDGFR effects in osteosarcoma and the “add-on” strategy
por: Xu, Jie, et al.
Publicado: (2018)

Identification of Biomarkers for Osteosarcoma Based on Integration Strategy
por: Bao, Junjie, et al.
Publicado: (2020)

Nanosized drug delivery strategies in osteosarcoma chemotherapy
por: Chen, Chenglong, et al.
Publicado: (2023)

Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma
por: Anand, Namrata, et al.
Publicado: (2023)

Switchable CAR T cell strategy against osteosarcoma
por: Hidalgo, Laura, et al.
Publicado: (2023)

EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance
por: Sevelda, Florian, et al.
Publicado: (2015)

Anticancer Effects of Geopropolis Produced by Stingless Bees on Canine Osteosarcoma Cells In Vitro
por: Cinegaglia, Naiara Costa, et al.
Publicado: (2013)

Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transport.
por: Hughes, J. M., et al.
Publicado: (1989)

Genomic Instability of Osteosarcoma Cell Lines in Culture: Impact on the Prediction of Metastasis Relevant Genes
por: Muff, Roman, et al.
Publicado: (2015)

Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma
por: Zhou, Yang, et al.
Publicado: (2022)

Recent Insights into Therapy Resistance in Osteosarcoma
por: Prudowsky, Zachary D., et al.
Publicado: (2020)

Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
por: Marchandet, Louise, et al.
Publicado: (2021)

Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
por: Lilienthal, Ingrid, et al.
Publicado: (2020)

Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing’s sarcoma
por: Dai, Xing, et al.
Publicado: (2011)

Novel molecular insights and new therapeutic strategies in osteosarcoma
por: Otoukesh, Babak, et al.
Publicado: (2018)

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
por: Korpal, Manav, et al.
Publicado: (2015)

In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice
por: Marques da Costa, Maria Eugénia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rpmfrec36n1nsbfn17mo91u8nh